What is Celldex Therapeutics's debt-to-assets?

Celldex Therapeutics (CLDX) reported debt-to-assets of 0× in Q1 2026.

How has Celldex Therapeutics's debt-to-assets changed year-over-year?

Celldex Therapeutics's debt-to-assets decreased by 19.6% year-over-year, from 0× to 0×.

What is the long-term trend for Celldex Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), Celldex Therapeutics's debt-to-assets has grown at a -23.0% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Celldex Therapeutics CLDX Debt-to-assets

Debt-to-assets at other companies

Eli LillyLLY

0.4×-0.1×

PfizerPFE

0.3×0.0×

Rogers CorporationROG

0×0.0×

AmgenAMGN

0.6×0.0×

Regeneron PharmaceuticalsREGN

0.1×0.0×

IncyteINCY

0×0.0×

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Calculated from Celldex Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's debt-to-assets?: Celldex Therapeutics (CLDX) reported debt-to-assets of 0× in Q1 2026.
How has Celldex Therapeutics's debt-to-assets changed year-over-year?: Celldex Therapeutics's debt-to-assets decreased by 19.6% year-over-year, from 0× to 0×.
What is the long-term trend for Celldex Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), Celldex Therapeutics's debt-to-assets has grown at a -23.0% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.